Drugs / Cytidine
Cytidine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT00854737 | Jul 2004 → Aug 2007 | bipolar disorder | Mclean Hospital | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT02640417 | Mar 2016 → Mar 2018 | — | Fundação Educacional Serra dos Órgãos | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01543139 Comparator | Dec 2015 → Apr 2017 | bipolar depression | Ewha Womans University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cytidine | “cytidine (2g po daily for 4 months)” NCT00854737 ↗ |
| Known as | CYT | “oral cytidine (CYT), a pyrimidine with reported preclinical and clinical antidepressant-like effects” PMID 22926607 ↗ Oct 2012 |
| Known as | MMV638723 | ChEMBL registry synonym — accepted as the source's own label CHEMBL95606 ↗ |
| Known as | NSC-20258 | ChEMBL registry synonym — accepted as the source's own label CHEMBL95606 ↗ |
| Modality | Small molecule | — CHEMBL95606 ↗ |
| Route | Oral | “cytidine (2g po daily for 4 months)” NCT00854737 ↗ |